+987.9%
MRNA vs GGLL
-11.6%
+999.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GGLL | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +6.5% | +6.6% | +11.5% |
| 7D | +20.6% | -23.1% | +43.8% | +26.4% |
| 30D | +27.1% | -32.9% | +60.0% | +38.4% |
| 3M | +353.4% | -44.9% | +398.3% | +413.3% |
| 6M | +446.3% | -49.5% | +495.8% | +532.7% |
| YTD | +776.2% | -28.9% | +805.1% | +809.2% |
| 1Y | +987.9% | -12.2% | +1,000.1% | +946.8% |
| All | +987.9% | -11.6% | +999.5% | +946.8% |
Cumulative growth
Daily Returns
Daily percentage return beside GGLL.
Daily Out/Under-Performance
Portfolio return minus GGLL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GGLL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GGLL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling